Join Lachman Consultants in Washington, DC, Sep 18-20, for the 2023 PDA/FDA Joint Regulatory Conference. Themed “CGMP: Quality Through Science and Innovation,” this year’s event will delve into the pivotal role effective quality systems play in ensuring an ongoing state of control throughout the product lifecycle.

As a Silver Sponsor at this year’s event, Lachman Consultants will be represented by President and CEO Fran Zipp, and our Director, Marketing & Client Engagement, Matt Taylor.

The flagship event will include:

  • A series of sessions covering robust systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management
  • Real-world case studies that provide tangible insights into these concepts
  • Discussions around how the international collaboration efforts are improving quality to the benefit of the consumer

As a leading life science and pharmaceutical quality and regulatory consultancy with advanced expertise in the local, regional, and international regulatory compliance landscape, Lachman will share insights and forward-thinking strategies around modern manufacturing, regulatory challenges, and emerging quality assurance practices.

Visit us at booth #30. We look forward to helping you find new ways to adapt, innovate, and drive excellence in product development and regulatory compliance!

For more information about the PDA/FDA Joint Regulatory Conference, click here.